Tiziana Life Sciences PLC (LON:TILS – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 58.50 ($0.76) and traded as low as GBX 45 ($0.58). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.76), with a volume of 297,127 shares changing hands.
Tiziana Life Sciences Trading Up 8.3 %
The business has a 50 day simple moving average of GBX 58.50 and a 200-day simple moving average of GBX 58.50. The company has a debt-to-equity ratio of 2.36, a quick ratio of 6.41 and a current ratio of 6.54. The stock has a market capitalization of £113.85 million and a P/E ratio of -3.59.
Tiziana Life Sciences Company Profile
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
Read More
- Five stocks we like better than Tiziana Life Sciences
- Buy P&G Now, Before It Sets A New All-Time High
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is a Dividend King?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.